Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


06.02.2017

2 Ann Oncol
11 Anticancer Res
1 Cancer Chemother Pharmacol
1 Cancer Lett
2 Cancer Sci
2 Clin Lung Cancer
1 Epidemiology
1 Eur J Cardiothorac Surg
3 J Clin Oncol
7 J Comput Assist Tomogr
1 J Natl Cancer Inst
1 J Thorac Oncol
1 Lancet Oncol
2 Mol Cancer Ther
1 Mol Carcinog
2 PLoS One
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. TSAO MS, Le Teuff G, Shepherd FA, Landais C, et al
    PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.
    Ann Oncol. 2017 Jan 30. pii: mdx003. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. LIANG J, Bi N, Wu S, Chen M, et al
    Etoposide and Cisplatin vs Paclitaxel and Carboplatin With Concurrent Thoracic Radiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Multicenter Randomized Phase III Trial.
    Ann Oncol. 2017 Jan 30. pii: mdx009. doi: 10.1093.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. PASQUALETTI F, Montrone S, Vivaldi C, Zani M, et al
    Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer.
    Anticancer Res. 2017;37:315-319.
    PubMed     Text format     Abstract available

  4. UGURLUER G, Chang K, Gamez ME, Arnett AL, et al
    Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.
    Anticancer Res. 2016;36:2331-8.
    PubMed     Text format     Abstract available

  5. FIALA O, Pesek M, Finek J, Topolcan O, et al
    Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.
    Anticancer Res. 2016;36:2459-65.
    PubMed     Text format     Abstract available

  6. AMBROSIO R, Ombra MN, Gridelli C, Picariello G, et al
    Isoflavone Extracts Enhance the Effect of Epidermal Growth Factor Receptor Inhibitors in NSCLC Cell Lines.
    Anticancer Res. 2016;36:5827-5833.
    PubMed     Text format     Abstract available

  7. YE X, Zhou Q, Matsumoto Y, Moriyama M, et al
    Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
    Anticancer Res. 2016;36:6021-6029.
    PubMed     Text format     Abstract available

  8. WATARAI H, Okada M, Kuramoto K, Takeda H, et al
    Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin.
    Anticancer Res. 2016;36:6083-6092.
    PubMed     Text format     Abstract available

  9. OKAZAKI I, Ishikawa S, Ando W, Sohara Y, et al
    Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens.
    Anticancer Res. 2016;36:6207-6224.
    PubMed     Text format     Abstract available

  10. SUNDARAM S, Yan L
    High-fat Diet Enhances Mammary Tumorigenesis and Pulmonary Metastasis and Alters Inflammatory and Angiogenic Profiles in MMTV-PyMT Mice.
    Anticancer Res. 2016;36:6279-6287.
    PubMed     Text format     Abstract available

  11. CHECK JH, Check D, Wilson C, Lofberg P, et al
    Long-term High-quality Survival with Single-agent Mifepristone Treatment Despite Advanced Cancer.
    Anticancer Res. 2016;36:6511-6513.
    PubMed     Text format     Abstract available

  12. GRIDELLI C, Chella A, Valmadre G, Allegrini G, et al
    Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized Trial.
    Anticancer Res. 2016;36:6535-6540.
    PubMed     Text format     Abstract available

  13. YANO S, Takehara K, Kishimoto H, Tazawa H, et al
    Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.
    Anticancer Res. 2017;37:57-60.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  14. SHIMIZU T, Yonesaka K, Hayashi H, Iwasa T, et al
    Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer.
    Cancer Chemother Pharmacol. 2017 Jan 31. doi: 10.1007/s00280-016-3231.
    PubMed     Text format     Abstract available


    Cancer Lett

  15. WANG J, Wang Y, Mei H, Yin Z, et al
    The BET Bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21.
    Cancer Lett. 2017 Jan 28. pii: S0304-3835(17)30072.
    PubMed     Text format     Abstract available


    Cancer Sci

  16. SAITO M, Shiraishi K, Kunitoh H, Takenoshita S, et al
    Gene aberrations for precision medicine against lung adenocarcinoma.
    Cancer Sci. 2016;107:713-20.
    PubMed     Text format     Abstract available

  17. FUJIWARA Y, Hamada A, Mizugaki H, Aikawa H, et al
    Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism.
    Cancer Sci. 2016;107:1117-23.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  18. JIANG T, Qiao M, Zhou F, Ren S, et al
    Effect of Combined Therapy Inhibiting EGFR and VEGFR Pathways in Non-Small-cell Lung Cancer on Progression-free and Overall Survival.
    Clin Lung Cancer. 2016 Dec 29. pii: S1525-7304(16)30388.
    PubMed     Text format     Abstract available

  19. LIM YJ, Chang JH, Kim HJ, Keam B, et al
    Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Clin Lung Cancer. 2016 Dec 28. pii: S1525-7304(16)30389.
    PubMed     Text format     Abstract available


    Epidemiology

  20. OLSSON AC, Vermeulen R, Schuz J, Kromhout H, et al
    Exposure-Response Analyses of Asbestos and Lung Cancer Subtypes in a Pooled Analysis of Case-Control Studies.
    Epidemiology. 2017;28:288-299.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  21. PEDERSEN JH, Rzyman W, Veronesi G, D'Amico TA, et al
    Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.
    Eur J Cardiothorac Surg. 2017 Jan 30. pii: ezw418. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Clin Oncol

  22. KUIJPERS W, Oldenburg HS, Wouters MW, Aaronson NK, et al
    Feasibility and preliminary efficacy of an interactive portal for lung cancer patients.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available

  23. TISEO M, Boni L, Ambrosio F, Camerini A, et al
    Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial.
    J Clin Oncol. 2017 Jan 30:JCO2016694844. doi: 10.1200/JCO.2016.69.4844.
    PubMed     Text format     Abstract available

  24. RYAN J, Fetrick A, Ganti AK
    Late-stage lung cancer patient preferences about chemotherapy treatment adverse side effects.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  25. SHROFF GS, Marom EM, Wu CC, Godoy MC, et al
    Pulmonary Legionellosis in Oncologic Patients: Findings on Chest CT.
    J Comput Assist Tomogr. 2016;40:917-922.
    PubMed     Text format     Abstract available

  26. LIN JZ, Zhang L, Zhang CY, Yang L, et al
    Application of Gemstone Spectral Computed Tomography Imaging in the Characterization of Solitary Pulmonary Nodules: Preliminary Result.
    J Comput Assist Tomogr. 2016;40:907-911.
    PubMed     Text format     Abstract available

  27. JIANG HY, Ma H, Qian W, Wei GH, et al
    Risk Analysis for Pathological Changes in Pulmonary Parenchyma Based on Lung Computed Tomography Images.
    J Comput Assist Tomogr. 2016;40:357-63.
    PubMed     Text format     Abstract available

  28. DEN HARDER AM, Willemink MJ, van Hamersvelt RW, Vonken EP, et al
    Pulmonary Nodule Volumetry at Different Low Computed Tomography Radiation Dose Levels With Hybrid and Model-Based Iterative Reconstruction: A Within Patient Analysis.
    J Comput Assist Tomogr. 2016;40:578-83.
    PubMed     Text format     Abstract available

  29. GIERADA DS, Politte DG, Zheng J, Schechtman KB, et al
    Quantitative Computed Tomography Classification of Lung Nodules: Initial Comparison of 2- and 3-Dimensional Analysis.
    J Comput Assist Tomogr. 2016;40:589-95.
    PubMed     Text format     Abstract available

  30. JENSEN K, Aalokken TM, Tingberg A, Fosse E, et al
    Image Quality in Oncologic Chest Computerized Tomography With Iterative Reconstruction: A Phantom Study.
    J Comput Assist Tomogr. 2016;40:351-6.
    PubMed     Text format     Abstract available

  31. TOMITA K, Hiraki T, Gobara H, Fujiwara H, et al
    Evaluation of Lung Radiofrequency Ablation With Dual-Energy Computed Tomography: Analysis of Tumor Composition and Lung Perfusion.
    J Comput Assist Tomogr. 2016;40:752-6.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  32. PELOSOF L, Ahn C, Gao A, Horn L, et al
    Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  33. HE Y, Yu H, Rozeboom L, Rivard CJ, et al
    LAG-3 Protein Expression in Non-small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.
    J Thorac Oncol. 2017 Jan 26. pii: S1556-0864(17)30043.
    PubMed     Text format     Abstract available


    Lancet Oncol

  34. BURKI TK
    Treatment options not taken for non-small-cell lung cancer.
    Lancet Oncol. 2017 Jan 27. pii: S1470-2045(17)30066.
    PubMed     Text format    


    Mol Cancer Ther

  35. NAKAMURA Y, Weaver Ohler Z, Householder D, Nagaya T, et al
    Near infrared photoimmunotherapy in a transgenic mouse model of spontaneous epidermal growth factor receptor (EGFR)-expressing lung cancer.
    Mol Cancer Ther. 2016 Nov 15. pii: molcanther.0663.2016.
    PubMed     Text format     Abstract available

  36. NANJO S, Arai S, Wang W, Takeuchi S, et al
    MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer.
    Mol Cancer Ther. 2017 Jan 30. pii: molcanther.0522.2016.
    PubMed     Text format     Abstract available


    Mol Carcinog

  37. YIN J, Liu H, Liu Z, Owzar K, et al
    Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus.
    Mol Carcinog. 2017 Feb 2. doi: 10.1002/mc.22622.
    PubMed     Text format     Abstract available


    PLoS One

  38. TAKASE Y, Usui K, Shimizu K, Kimura Y, et al
    Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method.
    PLoS One. 2017;12:e0171225.
    PubMed     Text format     Abstract available

  39. HOU LK, Ma YS, Han Y, Lu GX, et al
    Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
    PLoS One. 2017;12:e0170431.
    PubMed     Text format     Abstract available


    Thorax

  40. KENNEDY MP, Hall PS, Callister ME
    Secondary-care costs associated with lung cancer diagnosed at emergency hospitalisation in the United Kingdom.
    Thorax. 2017 Jan 30. pii: thoraxjnl-2016-209616.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: